false
OasisLMS
Catalog
Medical Student 8 Hour Buprenorphine Training
Session 6: MAT and Urine Drug Testing
Session 6: MAT and Urine Drug Testing
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The video is module 6 of a training course on buprenorphine induction, other medication options, and urine drug testing. Dr. Kelly Fedorio leads the module, discussing various topics related to buprenorphine induction. She explains that buprenorphine induction is the initiation of the medication in an opioid-dependent patient, with the goal of discontinuing full agonist opioids and starting buprenorphine. The specific goals of stabilization on buprenorphine include discontinuing other opioids, reducing withdrawal symptoms, minimizing side effects, and decreasing cravings. Patients must meet criteria for opioid use disorder, have a way to pay for treatment, and understand that urine drug testing will be conducted.<br /><br />Dr. Fedorio explains the two ways buprenorphine induction can be done: in-office or at home. For both methods, patients must be in mild to moderate withdrawal. She discusses the recommended doses and administration methods for buprenorphine and emphasizes the importance of patient education. She also mentions the various buprenorphine-naloxone combination products available and the considerations for choosing a specific product.<br /><br />The video then transitions to a discussion on medication options and urine drug testing. Dr. Fedorio explains the importance of urine drug testing for evaluating substance use, medication adherence, and treatment efficacy. She discusses the differences between screening tests and confirmatory tests, highlighting the limitations and benefits of each. The video concludes with a discussion on interpreting drug test results and potential interventions based on the results.<br /><br />No specific credits are mentioned in the video transcript.
Keywords
buprenorphine induction
medication options
urine drug testing
opioid-dependent patient
stabilization on buprenorphine
patient education
buprenorphine-naloxone combination products
urine drug testing importance
×
Please select your language
1
English